Daniel Verina, NP, Mount Sinai Health System
Advertisement
Articles by Daniel Verina, NP, Mount Sinai Health System
Advertisement
Latest Updated Articles
Study Overview: COLUMBA and PLEIADESPublished: May 13th 2020 | Updated:
Infusion-Related Adverse EventsPublished: May 13th 2020 | Updated:
Medication Supplements Prior to IV AdministrationPublished: May 13th 2020 | Updated:
Community Advice: SQ Formulation of DaratumumabPublished: May 13th 2020 | Updated:
Real-World Experience With SQ Monoclonal AntibodiesPublished: May 13th 2020 | Updated:
The Intravenous Administration of Monoclonal AntibodiesPublished: May 13th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5